Cellect Biotechnology (APOP) Reports Positive Results of Orthopedic Treatment Using ApoGraft on Enriched Stem Cells Derived from Fat Tissues
Tweet Send to a Friend
Cellect Biotechnology Ltd. (NASDAQ: APOP) announced today that it has achieved positive results on the use of human fat derived ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
